Southeast Asia, including Cambodia, is a hotspot of emerging and endemic infectious diseases, and the Institut Pasteur du Cambodge has been integral in searching for and combating these pathogens since its inception.
Exactly one year ago today, Institut Pasteur du Cambodge (IPC) identified the first confirmed case of COVID-19 in Cambodia. A long history of detecting and preventing emerging and endemic infectious diseases along with a rapid response to the global concern over “pneumonia of unknown origin” allowed IPC to be ready to test for SARS-CoV-2 in mid-January.
The FSPI project (Solidarity Funds for Innovative Projects) is entitled “Monitoring and Prevention of potential emerging viruses in Cambodia and Southeast Asia”. French Ministry of Europe and Foreign Affairs funded in 2019-2021 this project, supported by the French Embassy in Cambodia.
The Institut Pasteur du Cambodge (IPC) has been in the forefront of the global COVID-19 pandemic response in Cambodia since January, 2020. IPC remains fully committed to the pandemic response and working together with the Ministry of Health to combat COVID-19 in Cambodia.
It was our great pleasure to welcome M. Thomas Hundt, CEO of Smart Axiata and his corporate affairs team at Institut Pasteur du Cambodge.
The Institut Pasteur du Cambodge (IPC) remains fully committed to working together with the Ministry of Health to combat COVID-19 in Cambodia. As of 26 October 2020, IPC has performed more than 100,000 (one hundred thousand) COVID-19 molecular diagnostic tests by RT-PCR in the Virology Unit.
The COVID-19 pandemic once again draws attention on zoonotic diseases and their impact on public health. Over the last 20 years three of the major epidemics (Severe Acute Respiratory Syndrome – SARS, Middle East Respiratory Syndrome – MERS and the COVID-19) shows that potential transmission of pathogens from animal to humans are a serious threat to public health.
The Virology Unit under the leadership of Dr DUONG Veasna (Head of Unit) at the Institut Pasteur du Cambodge is proud to be part of an international consortium to combat Zika disease.
The Medical Biology Laboratory of the Institut Pasteur du Cambodge had its yearly surveillance audit by COFRAC (Comité Français d’Accréditation) on November 24 and 25, 2020. In the absence of critical deviation from international standards and requirements
In 2019, an estimated 10.0 million (range, 8.9 –11.0 million) people became ill with TB worldwide, of which 1.2 million were children. The vast majority of tuberculosis-related deaths occur in children that are not diagnosed and therefore not treated.